Sure. Here are some picked from recent TWiV episodes, which probably represents the polar opposite of the Brownstone Institute in terms of approach to science.

Sure. Here are some picked from recent TWiV episodes, which probably represents the polar opposite of the Brownstone Institute in terms of approach to science. https://www.cdc.gov/mmwr/volumes/70/wr/mm7040e1.htm https://www.cdc.gov/mmwr/volumes/70/wr/mm7040e1.htm "Implementation of high vaccination coverage coupled with multiple prevention strategies is critical to averting COVID-19 outbreaks in congregate settings, including overnight camps." https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3932953 https://papers.ssrn.com/sol3/papers.cfm?abstract_id=3932953 Efficacy of COVID-19 Vaccination on the Symptoms of Patients With Long COVID: A Target Trial Emulation Using Data From the ComPaRe e-Cohort in France "COVID-19 vaccination lowers the severity and life impact of long COVID at 120 days among patients with persistent symptoms." https://pubmed.ncbi.nlm.nih.gov/34587491/ https://pubmed.ncbi.nlm.nih.gov/34587491/ Emergency drug use in a pandemic: Harsh lessons from COVID-19 - this paper is not kind to those who have politicized HCQ and IVM. https://oklahoma.gov/content/dam/ok/en/covid19/documents/weekly-epi-report/2021.09.29%20Weekly%20Epi%20Report.pdf https://oklahoma.gov/content/dam/ok/en/covid19/documents/wee... Oklahoma reinfection rates - these show quite significant reinfection rates from those who have already had Covid, which is not consistent with the narrative pushed by antivaxxers that the vaccine provides little benefit for those with "natural immunity." https://www.researchsquare.com/article/rs-871965/v1 https://www.researchsquare.com/article/rs-871965/v1 Coronaviruses with a SARS-CoV-2-like receptor-binding domain allowing ACE2-mediated entry into human cells isolated from bats of Indochinese peninsula - this really hurts the "lab leak" case, providing more evidence pointing to zoonotic spillover from bats. https://www.nejm.org/doi/full/10.1056/NEJMoa2108891 https://www.nejm.org/doi/full/10.1056/NEJMoa2108891 Effectiveness of Covid-19 Vaccines against the B.1.617.2 (Delta) Variant "Overall, we found high levels of vaccine effectiveness against symptomatic disease with the delta variant after the receipt of two doses."